Published in J Clin Psychiatry on November 01, 2012
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord (2016) 0.75
Neuropsychological Assessment Battery-Screening Module (S-NAB): performance in treatment-seeking cocaine users. Am J Drug Alcohol Abuse (2014) 0.75
Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs. Psychiatry Res (2017) 0.75
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 6.03
The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med (2005) 5.81
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med (2006) 5.56
Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry (1991) 5.35
Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry (1993) 4.71
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry (1993) 3.59
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med (2006) 3.57
Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep (2010) 3.54
Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry (2000) 2.80
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry (2003) 2.66
Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry (1997) 2.49
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry (2006) 2.03
The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry (2010) 1.88
Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res (2007) 1.87
Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry (2005) 1.73
Screening for alcohol problems: what makes a test effective? Alcohol Res Health (2008) 1.53
Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat (2001) 1.42
Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry (2000) 1.42
Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend (1998) 1.25
History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry (1993) 1.22
The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med (2008) 1.19
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis (1999) 1.15
The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry (2007) 1.11
Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse (1999) 1.10
Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr (2008) 1.05
Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med (2006) 1.04
Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02
Psychometric properties of an adult ADHD diagnostic interview. J Atten Disord (2006) 1.00
Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacol Bull (1995) 0.98
Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity? J Atten Disord (2011) 0.84
[Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy]. Rev Neurol (2009) 0.83
Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Postgrad Med (2009) 0.83
Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry (2007) 0.80
Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis. J Clin Psychiatry (2007) 0.77
An examination of the psychometric properties of the attention deficit scales for adults with outpatient substance abusers. Am J Drug Alcohol Abuse (2007) 0.76
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA (2003) 5.19
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry (2010) 3.14
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr (2008) 2.78
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med (2005) 2.06
Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure. J Thorac Cardiovasc Surg (2005) 2.05
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol (2005) 1.94
Use of artificial tanning products among young adults. J Am Acad Dermatol (2006) 1.91
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J Bone Miner Res (2015) 1.60
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2008) 1.59
Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care (2005) 1.56
Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull (2009) 1.51
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci (2010) 1.45
Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. Am J Drug Alcohol Abuse (2011) 1.44
Maternal birthplace and breastfeeding initiation among term and preterm infants: a statewide assessment for Massachusetts. Pediatrics (2006) 1.44
Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization. Cancer (2004) 1.39
Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction (2013) 1.38
Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse (2007) 1.33
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer (2002) 1.27
Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend (2007) 1.26
Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin Cancer Res (2005) 1.26
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway. Cancer Res (2014) 1.14
The safety net: a cost-effective approach to improving breast and cervical cancer screening. J Womens Health (Larchmt) (2003) 1.13
Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs. Am J Drug Alcohol Abuse (2009) 1.09
Relationship power and sexual risk among women in community-based substance abuse treatment. J Urban Health (2009) 1.07
Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry (2011) 1.07
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry (2012) 1.05
Psychosis associated with modafinil and shift work. Am J Psychiatry (2005) 1.04
Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation. Front Psychiatry (2012) 1.03
"Who gets in?" Recruitment and screening processes of outpatient substance abuse trials. Addict Behav (2004) 1.02
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug Alcohol Depend (2007) 1.02
Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (2013) 1.01
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend (2010) 1.01
Baseline matters: the importance of covariation for baseline severity in the analysis of clinical trials. Am J Drug Alcohol Abuse (2011) 1.00
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Impact of a motivational intervention on mechanisms of change in low-income pregnant smokers. Addict Behav (2004) 0.95
Reduced mortality associated with breast-feeding-acquired HIV infection and breast-feeding among HIV-infected children in Zambia. J Acquir Immune Defic Syndr (2008) 0.95
Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug Alcohol Depend (2012) 0.94
In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model. J Bone Miner Res (2013) 0.93
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. J Dual Diagn (2009) 0.92
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend (2013) 0.92
Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials. Drug Alcohol Depend (2006) 0.92
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug Alcohol Depend (2011) 0.92
Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both? Drug Alcohol Depend (2003) 0.91
Concurrent use of tobacco and khat: added burden on chronic disease epidemic. Addiction (2012) 0.91
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety (2011) 0.90
Stress response dysregulation and stress-induced analgesia in nicotine dependent men and women. Biol Psychol (2012) 0.89
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend (2009) 0.89
Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychiatr Serv (2007) 0.89
Female condom skill and attitude: results from a NIDA Clinical Trials Network gender-specific HIV risk reduction study. AIDS Educ Prev (2011) 0.88
Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. Am J Addict (2004) 0.88
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am J Drug Alcohol Abuse (2006) 0.87
Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety (2012) 0.86
Discovery and validation of methylation markers for endometrial cancer. Int J Cancer (2014) 0.86
A stage I pilot study of acceptance and commitment therapy for methadone detoxification. Drug Alcohol Depend (2012) 0.86
Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatment. Am J Drug Alcohol Abuse (2009) 0.85
Predictors of internalizing and externalizing problems among children of cocaine and opiate dependent parents. Drug Alcohol Depend (2002) 0.84
A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. J Addict Dis (2010) 0.83
Moderators of delay tolerance in treatment-seeking cocaine users. Addict Behav (2006) 0.82
Predictors of relationship power among drug-involved women. AIDS Behav (2012) 0.82
Illusory predictors: Generalizability of findings in cocaine treatment retention research. Addict Behav (2007) 0.82
The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimul (2009) 0.81
Critical care medicine as a distinct product line with substantial financial profitability: the role of business planning. Crit Care Med (2004) 0.80
Baseline characteristics of patients predicting suitability for rapid naltrexone induction. Am J Addict (2015) 0.80
The role of patient expectancy in placebo and nocebo effects in antidepressant trials. J Clin Psychiatry (2014) 0.79
Personality disorders in hypochondriasis: prevalence and comparison with two anxiety disorders. Psychosomatics (2012) 0.79
Migratory birds and the spread of West Nile. Science (2003) 0.78
Comparison of substance use milestones in cannabis- and cocaine-dependent patients. J Addict Dis (2012) 0.78
The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial. Brain Stimul (2013) 0.78
Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. J Clin Psychopharmacol (2011) 0.77
External fixator pin tract infection model in the caprine (goat) tibia: a randomized, prospective, blinded study. Am J Orthop (Belle Mead NJ) (2004) 0.77
Open-label pilot study of quetiapine treatment for cannabis dependence. Am J Drug Alcohol Abuse (2014) 0.77
The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography. Eur Radiol (2006) 0.77
The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease. Acta Neuropathol Commun (2013) 0.77
Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia. Mov Disord (2009) 0.76
The development of the DSM-5 Cultural Formulation Interview-Fidelity Instrument (CFI-FI): a pilot study. J Health Care Poor Underserved (2014) 0.76
Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients. J Addict Med (2015) 0.75
Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'. Addiction (2015) 0.75
Comparison of 2 Measures of HIV Sexual Risk Behavior in Women in Outpatient Drug Treatment Programs. J Addict Med (2015) 0.75
Dysregulation of diurnal cortisol secretion affects abstinence induction during a lead-in period of a clinical trial for depressed cocaine-dependent patients. Am J Addict (2013) 0.75
Re: Promoting healthy skepticism in the news: helping journalists get it right. J Natl Cancer Inst (2010) 0.75
Evaluation of traumatic events as defined by the DSM-IV-TR criteria. Int J Psychiatry Clin Pract (2007) 0.75
Factors influencing intensive care admission: a mixed methods study of EM and ICU. Eur J Emerg Med (2017) 0.75
Baseline characteristics of patients predicting suitability for rapid naltrexone induction. Am J Addict (2014) 0.75
A case report of maintenance valproic acid treatment failing to protect against alcohol withdrawal. Am J Addict (2005) 0.75
Gila monster (Heloderma suspectum) envenomation: Descriptive analysis of calls to United States Poison Centers with focus on Arizona cases. Clin Toxicol (Phila) (2014) 0.75
Expanding treatment potential for substance use disorders. Psychiatr Clin North Am (2012) 0.75